Navigation Links
Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors
Date:12/12/2011

MENLO PARK, Calif., Dec. 12, 2011 /PRNewswire/ -- BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced that Michael Kleine, President & Chief Executive Officer of EndoGastric Solutions, Inc. has joined its Board of Directors.

"Mr. Kleine's impressive leadership experience in the field will accelerate the commercialization of our novel biologic cardiovascular therapies.  We are delighted to have him as part of the team," said Allan Mishra, MD, Founder of BioParadox.   

Mr. Kleine has more than 25 years of experience in the medical device and healthcare industries. He has successfully managed several global biomedical companies focused on the market advancement of numerous leading-edge products through commercialization strategies and operational excellence.

Previously, Mr. Kleine has served as President & Chief Executive Officer of Biosensors. After major restructuring of the Company, he achieved record revenue and market share gains by focusing on markets in Asia/Pacific, China and Europe. Under his leadership, the market cap of Biosensors grew from $187 million to $662 million. Prior to that, he served as President and Chief Executive Officer of Microvention Inc., a leading developer, manufacturer and marketer of minimally invasive products for treatment of cerebral and peripheral vascular disease.  During his tenure at Microvention, Mr. Kleine successfully grew the company until it was acquired by Terumo Corporation (Japan). 

Mr. Kleine also served as Chief Executive Officer of Thermo Cardiosystems Inc., an $80 million manufacturer and distributor of left ventricular assist systems, incision and blood coagulation devices, until its acquisition by Thoratec. He was also the former President and Chief Executive Officer of Sorin Biomedical Inc., a $54 million manufacturer and distributor of cardiopulmonary equipment that successfully merged with Cobe, Inc. and President of Bird Medical Technologies, a $64 million manufacturer and distributor of ventilators and disposable respirator and infection control products.

About BioParadox

BioParadox is innovating the use of Platelet Cell Therapy (PCT) for the treatment of cardiovascular disease. The company's first products, VitaKine® and RevaTen® are proprietary formulations that have been shown to enhance cardiovascular function. They are produced exclusively by BioParadox.

For more information, please visit: BioParadox.com or e-mail: info@bioparadox.com

 

 


'/>"/>
SOURCE BioParadox
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives
2. Hard To Treat Diseases (HTDS.PK) Stem Cells and Regenerative Medicine
3. Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes
4. Sigma-Aldrich Enters Distribution Agreement With Stemgent, Inc. to Offer Lentivirus-Based Gene Delivery Products for Regenerative Medicine and Stem Cell Research
5. The Impact of Very Small Embryonic-Like Stem Cells in Regenerative Medicine is Highlighted by Five Posters and Two Oral Presentations at the 2009 American Society of Hematology Annual Meeting
6. Speakers to Focus on Translating Regenerative Medicine Science
7. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
8. Audax Medical, Inc. Receives Therapeutic Discovery Grant for Development of Regenerative Bone Material
9. Reportlinker Adds Regenerative Medicine Markets
10. BioLife Solutions Increases 2011 Financial, Scientific, Technical Support of the Regenerative Medicine Industry
11. Lilly and the Juvenile Diabetes Research Foundation Partner to Fund Regenerative Medicine Research in Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):